Non-valvular atrial fibrillation (AF) and coronary artery disease with percutaneous revascularisation: safety of triple therapy with dabigatran

2 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Cardiovascular Pharmacotherapy Anticoagulants ACVC Premium Access Acute Cardiovascular Care 2019

ESC 365 is supported by

ESC 365 is supported by